Second Nature – Weekly Recap

Second Nature is an AI-driven sales training platform that uses virtual role-play to help enterprise sales teams practice and improve real-world conversations. This weekly recap reviews notable developments for the company, including new case studies, thought-leadership initiatives, and ongoing hiring activity that collectively signal sustained growth efforts.

During the week, Second Nature highlighted expanding traction in pharmaceutical sales enablement through its work with Pacira BioSciences, Inc., a company operating in a highly regulated, compliance-sensitive environment. Pacira’s reps are using Second Nature’s AI simulations to rehearse complex clinical discussions, with a focus on accuracy, regulatory adherence, and improved confidence in the field.

The pharma use case underscores the platform’s relevance in industries where messaging precision and documentation standards are critical, such as life sciences and broader healthcare. Positioning AI role-play as a standard part of training, rather than a novelty, indicates growing integration into customers’ workflows and may support recurring usage across large sales teams.

Second Nature also showcased a flagship case study with Oracle NetSuite, where its platform reportedly drove a 32% increase in sales opportunities and a 21% rise in sales volume after adoption. Additional metrics included a 20% reduction in onboarding time, a 21% decrease in time to first logo, and 2,400 hours of coaching delivered in a single quarter, highlighting the scalability advantages over traditional coaching.

The company emphasized analytics from millions of role plays linked to real performance data, arguing that higher practice intensity and exposure to diverse scenarios can yield revenue improvements of up to roughly 35%, particularly for lower-performing reps. This data-driven narrative directly connects training to financial outcomes, strengthening the ROI case for enterprise buyers and differentiating Second Nature from generic learning tools.

Thought-leadership efforts were another theme, with Second Nature promoting a webinar led by Dr. Coral Shachar on aligning training with cognitive science and brain function principles. By exploring how low-stakes AI simulations can drive durable learning while reducing stress, the company is reinforcing its focus on evidence-based, neuroscience-informed training design.

In parallel, Second Nature announced the hiring of an Associate Product Marketing Manager as part of continued expansion of its marketing organization. Growing headcount in go-to-market roles suggests ongoing investment in scaling awareness and adoption of its AI role-play solutions, even as it increases operating expenses to support broader market penetration.

Taken together, this week’s updates depict Second Nature deepening its presence in regulated verticals, sharpening its data and neuroscience-based value proposition, and investing in commercial expansion. Overall, the company appears to be reinforcing both the practical impact and scientific underpinnings of its AI-driven sales training model, supporting its positioning in the competitive sales enablement landscape.